Disease & disorder
monomorphic epitheliotropic intestinal T-cell lymphoma
MONDO:0958096
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Clinical trials
1 shownDrugs being studied
Research locations
AtlantaGeorgia, United States1AuroraColorado, United States1BostonMassachusetts, United States1ChicagoIllinois, United States1ColumbusOhio, United States1CommackNew York, United States1DuarteCalifornia, United States1HoustonTexas, United States1MiamiFlorida, United States1New HavenConnecticut, United States1New YorkNew York, United States1OmahaNebraska, United States1
Leading sponsors
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.